Viva Biotech Holdings (OTCMKTS:VBIZF – Get Free Report) rose 80% on Monday . The stock traded as high as $0.3434 and last traded at $0.3434. Approximately 1,682 shares were traded during mid-day trading, an increase of 62% from the average daily volume of 1,041 shares. The stock had previously closed at $0.1908.
Viva Biotech Trading Up 80.0%
The stock has a fifty day moving average of $0.23 and a 200-day moving average of $0.26.
About Viva Biotech
Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.
With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.
Read More
- Five stocks we like better than Viva Biotech
- How a Family Trust May Be Able To Help Preserve Your Wealth
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Viva Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viva Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
